ArticleAdvanced biotechnology2024
Impacts of ammoniacal odour removal bioagent on air bacterial community.
Article in Advanced biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Phages released from Acidithiobacillus ferrooxidans enhance chalcopyrite bioleaching by alleviating passivation and promoting sulfur turnover.Advanced biotechnology · 2026Article
- Microbial biotechnology: from synthetic biology to synthetic ecology.Advanced biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
While biotechnologies offer eco-friendly solutions for eliminating air contaminants, there is a scarcity of research examining the impacts of microbial purification of air pollutants on the structure and function of air microbial communities. In this study, we explored a Lactobacillus paracasei B1 (LAB) agent for removing ammoniacal odour. The impacts of LAB on air bacterial community were revealed. by analyzing the air samples before (BT) and after (AT) LAB bioagent treatment. Remarkably, the LAB bioagent significantly reduced the air ammonia concentration by 96.8%. This reduction was associated with a notable decline in bacterial diversity and a significant shift in community composition. The relative abundance of Staphylococcus, a common pathogen, plummeted from 1.91% to 0.03%. Moreover, other potential pathogens decreased by over 87%, signifying the bioagent's impactful role in diminishing health risks. The dominance of OTU-4 (Lactobacillus) highlighted its crucial role not only in competitive interactions but also potentially in shaping the metabolic pathways or community dynamics within the treated air microbial ecosystem. This shift towards deterministic assembly processes post-treatment, as highlighted by the normalized stochasticity ratio (NST), sheds light on the underlying mechanisms dictating the microbial community's response to bioagent interventions. The bioagent-purified air microbial community showed a strong preference for variable selection (88.9%), likely due to the acidity generated by the LAB. In conclusion, our findings emphasized the positive impact of LAB bioagent in enhancing air quality, which associated with the changes in microbial community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.